<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01938313</url>
  </required_header>
  <id_info>
    <org_study_id>SNUBH-ERAS-GC-PII</org_study_id>
    <nct_id>NCT01938313</nct_id>
  </id_info>
  <brief_title>Early Recovery After Surgery (ERAS) Versus Conventional Protocol After Laparoscopic Gastrectomy</brief_title>
  <acronym>ERAS</acronym>
  <official_title>Comparison of ERAS (Early Recovery After Surgery) Protocol With Conventional Protocol After Laparoscopic Gastrectomy: A Prospective Randomized Controlled Trial (Phase II Study))</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Enhanced Recovery After Surgery (ERAS) programs have been introduced with purposes of&#xD;
      reducing the surgical stress response and obtaining optimal recovery after surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is strong evidence of the usefulness of the ERAS programs in patients undergoing&#xD;
      colorectal surgery in terms of significantly reduced postoperative complications and shorter&#xD;
      length of hospital stay, compared to the patients of conventional treatment.&#xD;
&#xD;
      However, few studies exist about the implication of ERAS programs in the laparoscopic&#xD;
      gastrectomy.&#xD;
&#xD;
      The aim of this study was to compare the recovery rate, morbidity, and quality of life in the&#xD;
      patients undergoing laparoscopic gastrectomy for gastric cancer, receiving either ERAS&#xD;
      protocol or conventional postoperative cares.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recovering Rate</measure>
    <time_frame>4 days after surgery</time_frame>
    <description>Tolerance of diet for 24 hours A. Able to eat one third of more of soft-blend meal without abdominal discomfort, bloating, nausea, or vomiting&#xD;
Analgesic-free (oral or IV analgesic drugs not necessary after cessation of PCA)&#xD;
Safe ambulation (ambulation of 600m without assistance)&#xD;
Afebrile status without major complications (fever defined as body temperature greater than 37.5)&#xD;
Above total 4 criteria should be satisfied for the evaluation of complete recovery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative length of hospital stay</measure>
    <time_frame>up to 4 weeks after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to tolerance of a full diet</measure>
    <time_frame>up to 1 month after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first bowel motion Time to first bowel motion</measure>
    <time_frame>up to 7 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications during the admissionTime to first bowel motion</measure>
    <time_frame>up to 30 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission rate</measure>
    <time_frame>up to 30 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain scores based on a visual analog scale the day of surgery and the subsequent 3 days</measure>
    <time_frame>up to 3 days after surgery</time_frame>
    <description>postoperative 2hours, 6 hours, 1 days, 2 days, 3 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>up to 1 month after surgery</time_frame>
    <description>European organization for research and treatment of cancer (EORTC) and gastrointestinal quality of life index (GIQLI) questionnaire on postoperative 5 days, 1 month</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>ERAS perioperative cares</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients planned to undergoing laparoscopic gastrectomy, following the ERAS protocols.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional perioperative cares</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patents will be managed by our hospital's critical pathways.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ERAS perioperative cares</intervention_name>
    <description>Patient's preoperative counseling &amp; education before surgery&#xD;
No Bowel preparation&#xD;
Oral Carbohydrate Solution (OCS) loading until 2hours before surgery&#xD;
Fluid restriction &amp; Management by pulse contour analysis or transesophageal doppler&#xD;
Early mobilization&#xD;
Early oral feeding (postoperative 1 day - sips of water, 2 days - semifluid diet (SFD), 3 days - soft blended diet (SBD))&#xD;
Epidural patient controlled analgesics (no opioids analgesics)&#xD;
Postoperative Nausea Active Control&#xD;
Thromboembolism prophylaxis by low molecular weighted heparin (LMWH)&#xD;
Perioperative High content Oxygen therapy&#xD;
No drain insertion&#xD;
No Levin tube&#xD;
Patients will be discharged at POD#4 if there's no problem.</description>
    <arm_group_label>ERAS perioperative cares</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional perioperative cares</intervention_name>
    <description>No Patient's preoperative counseling &amp; education before surgery&#xD;
Bowel preparation&#xD;
No Oral Carbohydrate Solution (OCS) loading until 2hours before surgery&#xD;
Conventional Fluid Management by clinical signs (Urine output, heart rate etc.)&#xD;
Conventional Mobilization&#xD;
Conventional oral feeding (POD#2 SOW, #3 SFD, #4 SBD)&#xD;
IV PCA&#xD;
Postoperative Nausea Control if needed&#xD;
No Thromboembolism prophylaxis&#xD;
No or Low Content Oxygen therapy&#xD;
Routine drain insertion&#xD;
Levin tube insertion if needed</description>
    <arm_group_label>Conventional perioperative cares</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Elective surgery&#xD;
&#xD;
          -  American Society of Anesthesiologists (ASA) scores &lt; 3&#xD;
&#xD;
          -  20 &lt; Age &lt; 80&#xD;
&#xD;
          -  Gastric cancer, adenocarcinoma, possible to perform laparoscopic distal gastrectomy&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
          -  No other treatment (Radiation, Chemotherapy or Immunotherapy) on this gastric cancer&#xD;
             or other type of cancer.&#xD;
&#xD;
          -  No systemic inflammatory disease&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Emergency operation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hyung-Ho Kim, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Surgery, SNUBH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Geynggi</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <study_first_submitted>July 15, 2012</study_first_submitted>
  <study_first_submitted_qc>September 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2013</study_first_posted>
  <last_update_submitted>January 4, 2017</last_update_submitted>
  <last_update_submitted_qc>January 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Hyung-Ho Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>gastric cancer</keyword>
  <keyword>ERAS (early recovery after surgery)</keyword>
  <keyword>fast track</keyword>
  <keyword>laparoscopic gastrectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

